CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.

Clinical trial NCT03217643 · COMPLETED

Trial details

NCT number: NCT03217643
Sponsor: Imagine Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Enteropathy Associated T-cell Lymphoma

Start date: 2018-02-07
Primary completion: 2022-11-21
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.